Clinical Trials Directory

Trials / Completed

CompletedNCT05221346

Effect of Oleactiv® on LDL Oxidability

Effect of Oleactiv® on LDL Oxidability in Volunteers With Moderate Hypercholesterolemia - a Controlled, Randomized, Double-blind Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
26 (actual)
Sponsor
Institut Pasteur de Lille · Academic / Other
Sex
Male
Age
40 Years – 70 Years
Healthy volunteers
Accepted

Summary

Oleactiv® have previously demonstrated beneficial effects in an animal model of diet-induced atherosclerosis. After a 12-week supplementation, a substantial reduction of aortic fatty streak area has been observed. Also, Oleactiv®-supplemented hamsters displayed significant decrease of both non-HDL-cholesterol and triglycerides levels. Also, phenolic compounds from Oleactiv® demonstrated that increase of cholesterol efflux capacity (CEC) is one of the mechanisms that may explain preventive effect on atheroma development. These effects observed in animals will thus be investigated in human. The main hypothesis of the present study is that phenolic compounds from Oleactiv® may improve LDL oxidability in volunteers with moderate hypercholesterolemia after 3 weeks of consumption.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTPlant food supplementFood supplements are consumed during 3 weeks by hypercholesterolemic volunteers
DIETARY_SUPPLEMENTMaltodextrinFood supplements are consumed during 3 weeks by hypercholesterolemic volunteers

Timeline

Start date
2021-12-13
Primary completion
2022-10-11
Completion
2022-10-11
First posted
2022-02-03
Last updated
2022-12-07

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT05221346. Inclusion in this directory is not an endorsement.